edoc

Items where Author is "Lupatsch, J. E."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2020 | 2018
Number of items: 2.

2020

Panje, C. M. and Lupatsch, J. E. and Barbier, M. and Pardo, E. and Lorez, M. and Dedes, K. J. and Aebersold, D. M. and Plasswilm, L. and Gautschi, O. and Schwenkglenks, M. and Swiss Group for Clinical Cancer Research, . (2020) A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of Oncology, 31 (4). pp. 501-506.

2018

Hirschmann, A. and Lupatsch, J. E. and Schwenkglenks, M. and Panje, C. M. and Matter-Walstra, K. and Espeli, V. and Dedes, K. J. and Siano, M.. (2018) Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral oncology, 87. pp. 104-110.

This list was generated on Thu Apr 18 15:03:54 2024 CEST.